The current practice of breast imaging calls for using breast magnetic resonance imaging (MRI) only on high-risk patients with appropriate indications to maximize cancer detection yield and minimize the false-positive rate. Even with careful selection of patients, radiologists usually encounter…
Breast magnetic resonance imaging (MRI) has become an important part of the work-up of patients with newly diagnosed breast cancers. Although no large studies have proved a survival advantage, and questions remain as to whether preoperative MRI has reduced re-excision…
Ductal carcinoma in situ (DCIS) now makes up 20% to 30% of newly diagnosed breast cancers, an increase in detection that is largely attributed to the advent of screening mammography. Before the advent of screening mammography, DCIS made up about…
Breast cancer remains the second leading cause of cancer death in women. Mammography is the single large-scale method currently employed in screening for breast cancer in asymptomatic women. Although the effect of mammography in decreasing mortality is debated, multiple studies…
Optimal breast magnetic resonance imaging (MRI) interpretation depends on the image reader’s ability to both detect and accurately characterize contrast enhanced breast lesions. Detecting areas of enhancement involves the tedious process of comparing the precontrast and postcontrast sequences. This process…
Optimizing the breast magnetic resonance imaging (MRI) protocol requires many decisions to be made about image acquisition techniques, types of pulse sequences, and sequence parameters used to control image quality and acquisition speed. Fundamental trade-offs exist among spatial resolution, acquisition…
Breast magnetic resonance imaging (MRI) was introduced into the breast imaging community in the 1990s. A considerable number of research studies were conducted, with findings revealing promising results Breast MRI provided a novel approach to detecting breast cancer and diagnosing…